Enquiry

Specification Sheet

Docetaxel, 97%+

: 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}

: D 2402

: C43H53NO14

: 807.88

: Docetaxel, is a well-established anti-mitotic chemotherapy medication that works by interfering with cell division.

: D 2402 (OTTO) Docetaxel, 97%+ Cas 114977-28-5 - used to study the role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells.


Properties

: ≥97%

: Powder or chunks

: 186-192 °C (dec.)

: ~6% water


Safety Information

Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
WGK Germany 3
RTECS DA4172750


PackingsPrice (INR)
5 mg 15903.00
25 mg 40806.00
1 gm POR
100 gm POR